ERBB2 and Miyoshi myopathy: However, in the present study, Bor appeared to modulate EGFR levels in a cell line-dependent manner in MM, whereas more consistent effects were observed regarding ErbB2, whose levels were lowered by the proteasomal inhibitor in three out of the four MM cell lines investigated.